Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2021 | 04-2021 | 01-2021 | 10-2020 | 07-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,875 | 4,607 | 2,601 | 299 | -28,520 |
| Depreciation Amortization | 2,653 | 1,968 | 1,295 | 660 | 2,780 |
| Accounts receivable | -1,110 | -2,292 | -2,892 | -2,865 | 1,617 |
| Accounts payable and accrued liabilities | -395 | -2,473 | -4,062 | -658 | 1,214 |
| Other Working Capital | -4,774 | -7,092 | -6,186 | -2,697 | 7,957 |
| Other Operating Activity | -3,862 | 5,561 | 7,216 | 4,053 | -2,227 |
| Operating Cash Flow | $387 | $279 | $-2,028 | $-1,208 | $-17,179 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -30,061 | -30,023 | 0 | 0 | N/A |
| PPE Investments | -4,436 | -2,870 | -1,123 | -617 | -2,170 |
| Investing Cash Flow | $-34,497 | $-32,893 | $-1,123 | $-617 | $-2,170 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 7,412 |
| Debt Repayment | -339 | -283 | -207 | -113 | -411 |
| Common Stock Issued | 97 | 97 | N/A | N/A | N/A |
| Financing Cash Flow | $-242 | $-186 | $-207 | $-113 | $7,001 |
| Exchange Rate Effect | 11 | 24 | 29 | -13 | 67 |
| Beginning Cash Position | 48,615 | 48,615 | 48,615 | 48,615 | 60,896 |
| End Cash Position | 14,274 | 15,839 | 45,286 | 46,664 | 48,615 |
| Net Cash Flow | $-34,341 | $-32,776 | $-3,329 | $-1,951 | $-12,281 |
| Free Cash Flow | |||||
| Operating Cash Flow | 387 | 279 | -2,028 | -1,208 | -17,179 |
| Capital Expenditure | -4,436 | -2,870 | -1,123 | -617 | -2,170 |
| Free Cash Flow | -4,049 | -2,591 | -3,151 | -1,825 | -19,349 |